Keyphrases
Hepatitis C Virus Infection
100%
Gene Expression
100%
HNF1A
100%
Glucose Transporter 2 (GLUT2)
100%
Hepatitis C Virus
72%
Protease Inhibitors
36%
Protein Level
27%
JFH1
18%
MRNA Level
18%
Lysosomal Degradation
18%
Promoter Activity
18%
Infected Cells
18%
Lysosomal Acid Lipase
18%
Molecular Mechanism
9%
Amino Acids
9%
Type 2 Diabetes Mellitus (T2DM)
9%
Co-immunoprecipitation (co-IP)
9%
Overexpression
9%
Surface Expression
9%
NS5A
9%
Post-translational
9%
Hepatitis C Virus Replication
9%
Hepatitis C Virus RNA
9%
NS5 Protein
9%
Virus-infected Cell
9%
RNA Replicon
9%
Replicon Cell
9%
Transcriptional Regulation
9%
Cellular Glucose Uptake
9%
Binding Motif
9%
Extrahepatic Manifestations
9%
Glucose Metabolic Disorder
9%
Reporter Plasmid
9%
Immunology and Microbiology
Hepatitis C
100%
Gene Expression
100%
Downregulation
100%
Glucose Transporter
100%
Hepatocyte Nuclear Factor 1
100%
Hepatitis C Virus
90%
Promoter Region
36%
Proteasome
18%
NS5A
18%
Plasmid
9%
Immunoprecipitation
9%
Cell Surface
9%
Viral Replication
9%
Replicon Cell
9%
Glucose Transport
9%
Biochemistry, Genetics and Molecular Biology
Hepatitis C Virus
100%
Gene Expression
100%
Downregulation
100%
Glucose Transporter
100%
Hepatocyte Nuclear Factor 1
100%
Promoter Region
26%
Messenger RNA
13%
Protease Inhibitor
13%
NS5A
13%
Proteasome Inhibitor
13%
Amino Acids
6%
Virus Replication
6%
Surface Property
6%
Plasmid
6%
Glucose Transport
6%
Metabolic Disorder
6%
Immunoprecipitation
6%
RNA Virus
6%
Replicon
6%
Pharmacology, Toxicology and Pharmaceutical Science
Hepatitis C
100%
Hepatocyte Nuclear Factor 1
100%
Glucose Transporter 2
100%
Hepatitis C Virus
90%
Proteinase Inhibitor
18%
Proteasome Inhibitor
18%
Amino Acid
9%
Disease
9%
Non Insulin Dependent Diabetes Mellitus
9%
Virus RNA
9%
Metabolic Disorder
9%
Immunoprecipitation
9%
Nonstructural Protein 5A
9%